These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34155791)

  • 1. End-stage liver disease: Management of hepatorenal syndrome.
    Mauro E; Garcia-Olveira L; Gadano A
    Liver Int; 2021 Jun; 41 Suppl 1():119-127. PubMed ID: 34155791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis.
    Ma AT; Solé C; Juanola A; Escudé L; Napoleone L; Avitabile E; Pérez-Guasch M; Carol M; Pompili E; Gratacós-Ginés J; Soria A; Rubio AB; Cervera M; Moreta MJ; Morales-Ruiz M; Solà E; Poch E; Fabrellas N; Graupera I; Pose E; Ginès P
    J Hepatol; 2024 Sep; 81(3):441-450. PubMed ID: 38479614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population.
    Reddy KR; Weinberg EM; Gonzalez SA; Izzy MJ; Simonetto DA; Frederick RT; Rubin RA; Fricker Z; Ikahihifo-Bender J; Harte M; Garcia S; Campbell K; Olofson A; Razavi RF; James JM; Patel H; Kim-Lee G; Witkiewicz S; Tobin W; Jamil K
    Liver Transpl; 2024 Oct; 30(10):1026-1038. PubMed ID: 38771635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome.
    Piano S; Gambino C; Vettore E; Calvino V; Tonon M; Boccagni P; Gringeri E; Germani G; Burra P; Cillo U; Angeli P
    Hepatology; 2021 May; 73(5):1909-1919. PubMed ID: 32870499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review.
    Garcia-Tsao G; Abraldes JG; Rich NE; Wong VW
    Gastroenterology; 2024 Jan; 166(1):202-210. PubMed ID: 37978969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in terlipressin and transplantation in the United States: How do we MELD the two?
    Przybyszewski EM; Wilechansky RM; McLean Diaz P; Allegretti AS; VanWagner LB; Cullaro G; Levitsky J; Ginès P; Piano S; Asrani SK; Patidar KR;
    Liver Transpl; 2024 Jul; 30(7):753-759. PubMed ID: 38537069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI).
    Kulkarni AV; Lee J; Reddy KR
    Expert Rev Gastroenterol Hepatol; 2023; 17(11):1067-1079. PubMed ID: 37856367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MODIFIED TREATMENT OF HEPATORENAL SYNDROME TYPE I DEPENDING ON THE STAGE OF ACUTE KIDNEY INJURY.
    Slyvka N; Rusnak I; Zub L; Kulachek Y; Kulachek V; Al Salama M; Rovinskyi O
    Georgian Med News; 2021 May; (314):125-128. PubMed ID: 34248041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatorenal Syndrome: Pathophysiology, Diagnosis, and Treatment.
    Belcher JM
    Med Clin North Am; 2023 Jul; 107(4):781-792. PubMed ID: 37258014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review.
    Flamm SL; Wong F; Ahn J; Kamath PS
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2707-2716. PubMed ID: 36075500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US.
    Patidar KR; Belcher JM; Regner KR; St Hillien SA; Simonetto DA; Asrani SK; Neyra JA; Sharma P; Velez JCQ; Wadei H; Nadim MK; Chung RT; Seethapathy R; Parada XV; Ouyang T; Ufere NN; Robinson JE; McLean Diaz P; Wilechansky RM; Przybyszewski EM; Smith TN; Ali AA; Orman ES; Schulz P; Siddiqui SM; Shabbir R; Liu LJ; Cama-Olivares A; Flannery AH; Baker ML; Gunasekaran D; Aswine A; Issa R; Li J; Verma S; Chalmers D; Varghese V; Lam W; Mohamed M; Kovacic R; Gaddy A; Attieh RM; Cortes P; Semnani S; Wang L; Khemichian S; Allegretti AS;
    J Hepatol; 2023 Dec; 79(6):1408-1417. PubMed ID: 37517455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring Renal Function and Therapy of Hepatorenal Syndrome Patients with Cirrhosis.
    Juanola A; Solé C; Toapanta D; Ginès P; Solà E
    Clin Liver Dis; 2021 May; 25(2):441-460. PubMed ID: 33838860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin.
    Flamm SL; Brown K; Wadei HM; Brown RS; Kugelmas M; Samaniego-Picota M; Burra P; Poordad F; Saab S
    Liver Transpl; 2021 Aug; 27(8):1191-1202. PubMed ID: 33848394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatorenal syndrome in the era of acute kidney injury.
    Solé C; Pose E; Solà E; Ginès P
    Liver Int; 2018 Nov; 38(11):1891-1901. PubMed ID: 29845739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in management of hepatorenal syndrome.
    Khemichian S; Francoz C; Nadim MK
    Curr Opin Nephrol Hypertens; 2021 Sep; 30(5):501-506. PubMed ID: 34397647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Terlipressin Infusion in Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI): A Retrospective Observational Study.
    Gowda M; Dilipbhai DM; Jalihal U; Kumar MP; Gowda S B; Jain A; Ganjoo N
    Cureus; 2024 Aug; 16(8):e66581. PubMed ID: 39252705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival.
    Solé C; Solà E; Huelin P; Carol M; Moreira R; Cereijo U; Mas JM; Graupera I; Pose E; Napoleone L; dePrada G; Juanola A; Fabrellas N; Torres F; Morales-Ruiz M; Farrés J; Jiménez W; Ginès P
    Liver Int; 2019 Jul; 39(7):1246-1255. PubMed ID: 30597709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatorenal syndrome: Current concepts and future perspectives.
    Jung CY; Chang JW
    Clin Mol Hepatol; 2023 Oct; 29(4):891-908. PubMed ID: 37050843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin.
    Weinberg EM; Wong F; Vargas HE; Curry MP; Jamil K; Pappas SC; Sharma P; Reddy KR
    Liver Transpl; 2024 Apr; 30(4):347-355. PubMed ID: 37801553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure.
    Arora V; Maiwall R; Rajan V; Jindal A; Muralikrishna Shasthry S; Kumar G; Jain P; Sarin SK
    Hepatology; 2020 Feb; 71(2):600-610. PubMed ID: 30076614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.